Literature DB >> 15747137

Cholesterol granulomas in antrochoanal polyps: a clinicopathologic study.

Itzhak Shvili1, Tuvia Hadar, Jacob Shvero, Raphael Feinmesser, Rumelia Koren.   

Abstract

The purpose of this study was to investigate antrochoanal polyps with cholesterol granuloma (CG), which is a granulomatous reaction to cholesterol crystals that has been precipitated in the tissue. It is usually associated with chronic middle ear disease, common in the mastoid air cells, less common in the orbit and rarely found in the paranasal sinuses. The aim of this study was to analyze the etiology and pathological findings of antrochoanal polyps associated with cholesterol granuloma. This is a retrospective study of five cases of antrochoanal polyp with cholesterol granuloma, (four males and one female between 15 and 77 years of age) who presented with nasal obstruction, rhinorhea and snoring. The cases were clinically and histologically reviewed. Four patients were treated endoscopically and one by intranasal polypectomy without endoscope. There was no recurrence during the follow-up between 24 to 36 months (mean 31.2 months). Five uncommon cases with antrochoanal polyp with cholesterol granuloma are presented. The cholesterol granulomas consist of fibrous granulation tissue containing cholesterol crystals with surrounding foreign body giant cells. The pathogenesis of antrochoanal polyp with cholesterol granuloma is unclear, and further investigations are needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15747137     DOI: 10.1007/s00405-004-0898-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  27 in total

1.  Secretory cysts of the maxillary antrum and their relation to the development of antrochoanal polypi.

Authors:  C P MILLS
Journal:  J Laryngol Otol       Date:  1959-05       Impact factor: 1.469

2.  Epistaxis as an unusual presentation of an antrochoanal polyp.

Authors:  A K Robson; C S Barker; H B Whittet
Journal:  J Laryngol Otol       Date:  1990-08       Impact factor: 1.469

3.  Cholesterol granuloma of the maxillary sinus.

Authors:  Marino E Leon; Carlos Chavez; Billie Fyfe; Matthew J Nagorsky; Fernando U Garcia
Journal:  Arch Pathol Lab Med       Date:  2002-02       Impact factor: 5.534

4.  Removal of antral polyp through an extended nasoantral window.

Authors:  D Ophir; G Marshak
Journal:  Laryngoscope       Date:  1987-11       Impact factor: 3.325

5.  Cholesterol granuloma of the peritoneum.

Authors:  A F al-Amer; H S Walia; J P Madda
Journal:  Can J Surg       Date:  1990-10       Impact factor: 2.089

Review 6.  Cholesterol granulomas of the maxillary sinus presenting with nasal obstruction.

Authors:  L Rath-Wolfson; Y P Talmi; M Halpern; I Levit; Y Zohar; R Gal
Journal:  Otolaryngol Head Neck Surg       Date:  1993-11       Impact factor: 3.497

7.  The role of transcanine surgery in antrochoanal polyps.

Authors:  A el-Guindy; M H Mansour
Journal:  J Laryngol Otol       Date:  1994-12       Impact factor: 1.469

8.  Cholesterol granuloma of the maxillary antrum.

Authors:  H A Gunes; A Almac; E Canbay
Journal:  J Laryngol Otol       Date:  1988-07       Impact factor: 1.469

9.  Histologic structure of antrochoanal polyps.

Authors:  Y G Min; J W Chung; J S Shin; J G Chi
Journal:  Acta Otolaryngol       Date:  1995-07       Impact factor: 1.494

10.  Cholesterol granuloma of the petrous apex and sphenoidal sinus: a case report.

Authors:  W C Gray; M Salcman; K C Rao; M A Hafiz
Journal:  Neurosurgery       Date:  1985-07       Impact factor: 4.654

View more
  2 in total

1.  Fenestration is a logical and effective treatment for a large primordial cyst with cholesterol granuloma: a case report.

Authors:  Jun-Ichi Akutsu; Teruaki Iwahashi; Yoshiki Nariai
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

2.  Cholesterol granuloma in thyroglossal cysts: a clinicopathological study.

Authors:  Itzhak Shvili; Tuvia Hadar; Rima Sadov; Rumelia Koren; Jacob Shvero
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02-11       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.